Ophthalmology Doctors in Katy, TX Accepting Medicare

5 Ophthalmology doctors found. Showing 1 - 5

Dr. Randolph P Whitford, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 21318 Provincial Blvd, Katy, TX 77450 Phone: 281-398-0747    Fax: 281-398-9825

Mrs. Donna Marie Talluto, M.D. Ophthalmology - Glaucoma Specialist Medicare: Accepting Medicare Assignments Practice Location: 21502 Merchants Way, Katy, TX 77449 Phone: 281-579-6777    Fax: 287-578-6534

Fernando A. Romero, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 701 S Fry Rd, Ste 120 Fernando A. Romero, Md, Pa, Katy, TX 77450 Phone: 281-492-8982    Fax: 281-492-6184

Dr. Erin Andrew Doe, MD Ophthalmology - Glaucoma Specialist Medicare: Accepting Medicare Assignments Practice Location: 21502 Merchants Way, Katy, TX 77449 Phone: 281-579-6777    Fax: 281-578-6534

Mr. Brian Donald Wright, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 750 Westgreen Blvd, Katy, TX 77450 Phone: 281-392-3937    Fax: 281-392-8671

News Archive

PSI showcases evidence-based HIV prevention methods at International AIDS Conference

Technical staff from PSI, a leading global health organization operating in more than 60 countries around the world, are currently attending the 18th International AIDS Conference in Vienna to showcase PSI's innovative, evidence-based HIV prevention methods, which have helped to successfully avert more than one billion cases of HIV infection over the past 40 years.

Long daily sedentary periods cause a health risk despite physical activity

Good physical condition is a route to better health, and in order to improve it, exercising several days a week is recommended. Although it is possible to become healthier by exercising, long daily sedentary periods cause a health risk despite physical activity.

Smoking genes do not trigger heavier drinking, shows research

Some smokers have genes that predispose them to heavier smoking. Researchers looked at whether those same genes might trigger heavier drinking — and it turns out, they don't.

Athersys completes enrollment in phase I MultiStem allogeneic stem cell therapy clinical trial

Athersys, Inc. and Angiotech Pharmaceuticals, Inc. announced that Athersys has completed patient enrollment for its phase I clinical trial of MultiStem(R), its allogeneic stem cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. Top line results of the trial are expected to be announced midyear, upon completion of the four-month patient follow-up visits and analysis of results.

Read more Medical News

› Verified 2 days ago